Nano-X Imaging (NNOX)
Search documents
Nano-X Imaging (NNOX) - 2023 Q3 - Earnings Call Transcript
2023-11-28 17:29
Company Participants Good day, and thank you for standing by. Welcome to the Nano-X Q3 2023 Earnings Conference Call. [Operator Instructions] Nano-X Imaging Ltd (NASDAQ:NNOX) Q3 2023 Earnings Conference Call November 28, 2023 8:30 AM ET Conference Call Participants And I would now like to turn the conference over to your speaker today, Mr. Mike Cavanaugh, Investor Relations. Sir, please go ahead. Good afternoon, and thank you for joining us today. Earlier today, Nano-X Imaging Ltd. released financial result ...
Nano-X Imaging (NNOX) - 2023 Q4 - Annual Report
2023-11-28 13:20
Exhibit 99.1 Nanox Announces Third Quarter of 2023 Financial Results and Provides Business Update Reports progress towards global supply chain development and commercial deployment Ended the third quarter of 2023 with cash, cash equivalents, restricted cash and marketable securities of $95.6 million Management to host conference call and webcast Tuesday, November 28, 2023 at 8:30 AM ET Management to host investor day on December 4, 2023 NEVE ILAN, Israel— November 28, 2023 — NANO-X IMAGING LTD (NASDAQ: NNOX ...
Nano-X Imaging (NNOX) - 2023 Q2 - Earnings Call Transcript
2023-08-17 15:34
Company Participants Conference Call Participants Operator I would like now to turn the conference over to Mike Cavanaugh, Investor Relations. Please go ahead. Good afternoon, and thank you for joining us today. Earlier today, Nano-X Imaging Ltd. released financial results for the quarter ended June 30, 2023. The release is currently available on the Investors section of the company's site. Erez Meltzer, Chief Executive Officer; and Ran Daniel, Chief Financial Officer, will host this morning's call. Managem ...
Nano-X Imaging (NNOX) - 2023 Q3 - Quarterly Report
2023-08-17 12:05
Exhibit 99.1 Nanox Announces Third Quarter of 2023 Financial Results and Provides Business Update Reports progress towards global supply chain development and commercial deployment Ended the third quarter of 2023 with cash, cash equivalents, restricted cash and marketable securities of $95.6 million Management to host conference call and webcast Tuesday, November 28, 2023 at 8:30 AM ET Management to host investor day on December 4, 2023 NEVE ILAN, Israel— November 28, 2023 — NANO-X IMAGING LTD (NASDAQ: NNOX ...
Nano-X Imaging (NNOX) - 2023 Q1 - Earnings Call Transcript
2023-05-22 15:38
Nano-X Imaging Ltd. (NASDAQ:NNOX) Q1 2023 Results Conference Call May 22, 2023 8:30 AM ET Conference Call Participants Good day, and welcome to the Nano-X Q1 2023 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation there will be a question-and-answer session. Instructions will be given at that time. As a reminder, this call may be recorded. Good afternoon and thank you for joining us today. Earlier today, Nano-X Imaging Ltd. released financial results fo ...
Nano-X Imaging (NNOX) - 2023 Q2 - Quarterly Report
2023-05-22 12:01
Exhibit 99.1 Nanox Announces Second Quarter of 2023 Financial Results and Provides Business Update Reports progress towards global supply chain development Ended the second quarter of 2023 with cash, cash equivalents, restricted cash and marketable securities of $80.3 million Management to host conference call and webcast Thursday, August 17, 2023 at 8:30 AM ET NEVE ILAN, Israel— August 17, 2023 -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company ...
Nano-X Imaging (NNOX) - 2022 Q4 - Annual Report
2023-05-01 12:57
Exhibit 99.1 Nanox.ARC Imaging System Receives FDA Clearance, Pioneering a New Era in Medical Imaging - Nanox.ARC presents high powered digital X-ray tubes for 3D tomosynthesis imaging - Nanox.ARC could help expand the availability of medical imaging NEVE ILAN, Israel, May 1, 2023 (GLOBE NEWSWIRE) – NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has received a 510(k) clearance from the U.S. Food and Drug Administration ( ...
Nano-X Imaging (NNOX) - 2022 Q4 - Annual Report
2023-05-01 10:37
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...
Nano-X Imaging (NNOX) - 2022 Q4 - Earnings Call Transcript
2023-03-09 18:58
Company Participants Good day, and welcome to the Nano-X Q4 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. Factors that may cause such a difference include, but are not limited to, those described in the company's filings with the Securities and Exchange Commission. We will also refer to certain non-GAAP fi ...
Nano-X Imaging (NNOX) - 2023 Q1 - Quarterly Report
2023-03-09 13:05
Exhibit 99.1 Nanox Announces Fourth Quarter 2022 Financial Results and Provides Business Update Reports progress towards global supply chain development Ended the fourth quarter of 2022 with cash, cash equivalents and marketable securities of $102.9 million Management to host conference call and webcast Thursday, March 9, 2023 at 8:30 AM ET NEVE ILAN, Israel— March 9, 2023 -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced resul ...